Search

Your search keyword '"Kelley, Colleen"' showing total 845 results

Search Constraints

Start Over You searched for: Author "Kelley, Colleen" Remove constraint Author: "Kelley, Colleen"
845 results on '"Kelley, Colleen"'

Search Results

1. Correction: Disparities in Care Outcomes in Atlanta Between Black and White Men Who Have Sex With Men Living With HIV: Protocol for a Prospective Cohort Study (Engage[men]t)

2. Detection of SARS-CoV-2 RNA and Antibodies in Diverse Samples: Protocol to Validate the Sufficiency of Provider-Observed, Home-Collected Blood, Saliva, and Oropharyngeal Samples

3. HPTN 083‐02: factors influencing adherence to injectable PrEP and retention in an injectable PrEP study

5. Heterologous cAd3-Ebola and MVA-EbolaZ vaccines are safe and immunogenic in US and Uganda phase 1/1b trials

6. Prevalence of SARS-CoV-2 Infection among Children and Adults in 15 US Communities, 20211

7. The Comparability of Men Who Have Sex With Men Recruited From Venue-Time-Space Sampling and Facebook: A Cohort Study

8. Baricitinib versus dexamethasone for adults hospitalised with COVID-19 (ACTT-4): a randomised, double-blind, double placebo-controlled trial.

9. Lenzilumab in hospitalised patients with COVID-19 pneumonia (LIVE-AIR): a phase 3, randomised, placebo-controlled trial.

11. Immunomodulators for immunocompromised patients hospitalized for COVID-19: a meta-analysis of randomized controlled trials

13. Cabotegravir for HIV Prevention in Cisgender Men and Transgender Women

14. Efficacy, safety, tolerability, and pharmacokinetics of long-acting injectable cabotegravir for HIV pre-exposure prophylaxis in transgender women: a secondary analysis of the HPTN 083 trial

15. Risk of COVID-19 after natural infection or vaccination

16. Analysis of Factors That Affect the Nature and Quality of Student Laboratory Argumentation

17. “Cure” Versus “Clinical Remission”: The Impact of a Medication Description on the Willingness of People Living with HIV to Take a Medication

18. Baricitinib versus dexamethasone for adults hospitalised with COVID-19 (ACTT-4): a randomised, double-blind, double placebo-controlled trial

19. Exploring the Impact of the Framing of a Laboratory Experiment on the Nature of Student Argumentation

20. Safety and immunogenicity of a trivalent virus-like particle vaccine against western, eastern, and Venezuelan equine encephalitis viruses: a phase 1, open-label, dose-escalation, randomised clinical trial

21. Lenzilumab in hospitalised patients with COVID-19 pneumonia (LIVE-AIR): a phase 3, randomised, placebo-controlled trial

22. Doxycycline post-exposure prophylaxis for sexually transmitted infections impacts the gut antimicrobial resistome

23. Preventing Premature PrEP Discontinuation and Sexually Transmitted Infections among Men Who Have Sex with Men: Protocol for Prospective Cohort Study (Project PEACH) (Preprint)

24. Corrigendum to – “Single oral dose for HIV pre or post-exposure prophylaxis: user desirability and biological efficacy in macaques” [eBioMedicine 58(2020) 102894]

27. Understanding disparities in viral suppression among Black MSM living with HIV in Atlanta Georgia

28. Oral Preexposure Prophylaxis Uptake and Discontinuation in the HIV Vaccine Trials Network 704/HIV Prevention Trials Network 085 Study: Implications for Biomedical Human Immunodeficiency Virus Prevention Trials.

30. Early Tecovirimat Treatment for Mpox Disease Among People With HIV

32. The Importance of Time to Think Back: The Role of Reminding in Retroactive Effects of Memory

34. Phase 1 Open-Label Dose Escalation Trial for the Development of a Human Bacillus Calmette-Guérin Challenge Model for Assessment of Tuberculosis Immunity In Vivo.

35. Impact of LS Mutation on Pharmacokinetics of Preventive HIV Broadly Neutralizing Monoclonal Antibodies: A Cross-Protocol Analysis of 16 Clinical Trials in People without HIV.

36. Associations Between HIV and Severe Mpox in an Atlanta Cohort.

37. Phase 1 Open-Label Dose Escalation Trial for the Development of a Human Bacillus Calmette-Guérin Challenge Model for Assessment of Tuberculosis Immunity In Vivo

38. 2896. Oral PrEP Uptake among HVTN 704/HPTN 085 Participants: Implications for the Future of Biomedical HIV Prevention Trials

39. Associations between HIV and Severe Mpox in an Atlanta Cohort

40. Risk of COVID-19 after natural infection or vaccination

41. Efficacy, safety, tolerability, and pharmacokinetics of long-acting injectable cabotegravir for HIV pre-exposure prophylaxis in transgender women: a secondary analysis of the HPTN 083 trial

47. Safety, tolerability, and immunogenicity of two Zika virus DNA vaccine candidates in healthy adults: randomised, open-label, phase 1 clinical trials

48. Lack of health insurance is associated with delays in PrEP initiation among young black men who have sex with men in Atlanta, US: a longitudinal cohort study

50. Taking It to the Classroom: Strategies for Re-Claiming Citizenship through Communication Education.

Catalog

Books, media, physical & digital resources